PL3351936T3 - Test odpowiedzi immunologicznej pośredniczonej przez komórki o podwyższonej czułości - Google Patents

Test odpowiedzi immunologicznej pośredniczonej przez komórki o podwyższonej czułości

Info

Publication number
PL3351936T3
PL3351936T3 PL18158828.6T PL18158828T PL3351936T3 PL 3351936 T3 PL3351936 T3 PL 3351936T3 PL 18158828 T PL18158828 T PL 18158828T PL 3351936 T3 PL3351936 T3 PL 3351936T3
Authority
PL
Poland
Prior art keywords
immune response
cell mediated
mediated immune
enhanced sensitivity
response assay
Prior art date
Application number
PL18158828.6T
Other languages
English (en)
Inventor
Jeff Boyle
Original Assignee
QIAGEN Australia Holding Pty. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47423289&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3351936(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by QIAGEN Australia Holding Pty. Ltd. filed Critical QIAGEN Australia Holding Pty. Ltd.
Publication of PL3351936T3 publication Critical patent/PL3351936T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/505Cells of the immune system involving T-cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
PL18158828.6T 2011-06-29 2012-06-27 Test odpowiedzi immunologicznej pośredniczonej przez komórki o podwyższonej czułości PL3351936T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161502811P 2011-06-29 2011-06-29

Publications (1)

Publication Number Publication Date
PL3351936T3 true PL3351936T3 (pl) 2025-05-05

Family

ID=47423289

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18158828.6T PL3351936T3 (pl) 2011-06-29 2012-06-27 Test odpowiedzi immunologicznej pośredniczonej przez komórki o podwyższonej czułości

Country Status (22)

Country Link
US (3) US9983207B2 (pl)
EP (3) EP2726883B2 (pl)
JP (1) JP6150177B2 (pl)
KR (1) KR102022513B1 (pl)
CN (3) CN108593936B (pl)
AU (5) AU2012276280B2 (pl)
BR (1) BR112013033520B1 (pl)
CA (1) CA2840484C (pl)
CY (1) CY1120633T1 (pl)
DK (2) DK2726883T4 (pl)
ES (2) ES2673697T5 (pl)
FI (1) FI3351936T3 (pl)
HU (2) HUE070908T2 (pl)
LT (2) LT3351936T (pl)
MX (1) MX357717B (pl)
PL (1) PL3351936T3 (pl)
PT (2) PT3351936T (pl)
RU (2) RU2647468C2 (pl)
SI (2) SI3351936T1 (pl)
TR (1) TR201808740T4 (pl)
WO (1) WO2013000021A1 (pl)
ZA (1) ZA201309155B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010060155A1 (en) 2008-11-30 2010-06-03 Nexpep Pty Ltd Compositions and methods for treatment of celiac disease
JP2012167952A (ja) * 2011-02-10 2012-09-06 Central Automotive Products Ltd アルコール検知器
CA2840484C (en) 2011-06-29 2020-04-14 Cellestis Limited A cell mediated immune response assay with enhanced sensitivity
JP6123282B2 (ja) * 2012-12-20 2017-05-10 富士電機株式会社 プログラマブルコントローラおよび電源切断対処方法
US10564150B2 (en) * 2012-12-28 2020-02-18 Cellestis Limited Cell mediated immune response assay
JP2014229116A (ja) * 2013-05-23 2014-12-08 富士電機株式会社 プログラマブルコントローラおよび電源切断対処方法
CA2923822A1 (en) 2013-09-10 2015-03-19 Immusant, Inc. Dosage of a gluten peptide composition
US10370718B2 (en) 2014-09-29 2019-08-06 Immusant, Inc. Use of HLA genetic status to assess or select treatment of celiac disease
KR20170071507A (ko) 2014-10-23 2017-06-23 퀴아젠 사이언시스, 엘엘씨 펩티드 조성물 및 그의 용도
WO2016198470A2 (en) 2015-06-08 2016-12-15 Lophius Biosciences Gmbh Composition for determination of cell-mediated immune responsiveness
GB201605210D0 (en) * 2016-03-29 2016-05-11 Oxford Immunotec Ltd Assay
JP2021522519A (ja) * 2018-04-19 2021-08-30 スティッキーセル ピーティーワイ リミテッドStickycell Pty Ltd 感染症の技術分野における白血球補充
US20210396759A1 (en) * 2018-05-11 2021-12-23 Obi Pharma, Inc. Method for Predicting Human Immune Response
JP6796737B1 (ja) * 2020-06-02 2020-12-09 振武 曽 多項目自動血球計数装置
WO2022008973A2 (en) * 2020-07-10 2022-01-13 Covid Diagnostics Ltd. Compositions, methods, and systems for detecting immune response
CN114062665B (zh) * 2020-08-05 2023-04-28 菲鹏生物股份有限公司 示踪粒子标记目标分子及其制备方法和应用
CN113238060B (zh) * 2021-05-08 2022-10-11 迈克生物股份有限公司 用于预测或诊断心肌炎的试剂盒
WO2024263622A1 (en) * 2023-06-19 2024-12-26 Immune Functional Diagnostics, Llc Methods and assays for immune phenotyping

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
DE69941545D1 (de) 1998-11-04 2009-11-26 Isis Innovation Tuberkulose diagnose test
US20020131976A1 (en) 1998-12-23 2002-09-19 Ajit Lalvani Tuberculosis vaccine
AU4328801A (en) * 2000-02-24 2001-09-03 Xcyte Therapies Inc Simultaneous stimulation and concentration of cells
AUPQ689900A0 (en) 2000-04-14 2000-05-11 Commonwealth Scientific And Industrial Research Organisation Bubble acoustics
WO2003031469A2 (de) * 2001-10-02 2003-04-17 Mologen Ag Mittel zur verbesserung der immunantwort
RU2311911C2 (ru) * 2002-07-05 2007-12-10 Липоксен Текнолоджиз Лимитед Способ усиления иммунного ответа при вакцинации нуклеиновой кислотой
ITRM20040091A1 (it) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
WO2005118629A1 (en) 2004-06-02 2005-12-15 Diatech Pty Ltd BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS
AU2008229636B2 (en) * 2007-03-16 2014-08-14 Qiagen Sciences Llc A cell-mediated immune response assay and kits therefor
EP2190468A2 (en) * 2007-08-30 2010-06-02 Genentech, Inc. Methods and compositions for modulating t cells
EP2106803A1 (en) * 2008-04-04 2009-10-07 Fondazione Centro San Raffaele del Monte Tabor Method to design and uses of overlapping peptides for monitoring T-cell responses in HIV patients
CN102066939A (zh) * 2008-04-23 2011-05-18 健康诊断有限公司 检测妇科病症的测定法
WO2010009494A1 (en) * 2008-07-25 2010-01-28 Cellestis Limited A diagnostic method
WO2011075773A1 (en) 2009-12-23 2011-06-30 Cellestis Limited An assay for measuring cell-mediated immunoresponsiveness
CA2840484C (en) 2011-06-29 2020-04-14 Cellestis Limited A cell mediated immune response assay with enhanced sensitivity

Also Published As

Publication number Publication date
EP2726883B2 (en) 2022-05-18
EP2726883A4 (en) 2015-02-18
WO2013000021A1 (en) 2013-01-03
HUE037801T2 (hu) 2018-09-28
CA2840484C (en) 2020-04-14
EP3351936B1 (en) 2025-01-08
JP6150177B2 (ja) 2017-06-21
AU2022202799A1 (en) 2022-05-19
PT2726883T (pt) 2018-06-05
US20250369968A1 (en) 2025-12-04
ZA201309155B (en) 2015-03-25
RU2018107763A (ru) 2019-02-25
KR20140066991A (ko) 2014-06-03
SI2726883T2 (sl) 2022-09-30
RU2647468C2 (ru) 2018-03-15
JP2014521052A (ja) 2014-08-25
AU2012276280B2 (en) 2017-05-25
EP3351936A1 (en) 2018-07-25
CN108593936A (zh) 2018-09-28
CN115144594A (zh) 2022-10-04
AU2019222928B2 (en) 2022-02-03
HUE070908T2 (hu) 2025-07-28
AU2017213471A1 (en) 2017-08-31
CN108593936B (zh) 2022-05-13
EP4556906A3 (en) 2025-08-06
BR112013033520A8 (pt) 2018-07-17
ES2673697T3 (es) 2018-06-25
KR102022513B1 (ko) 2019-09-19
SI2726883T1 (en) 2018-06-29
CN103703375A (zh) 2014-04-02
PT3351936T (pt) 2025-02-03
US20140220601A1 (en) 2014-08-07
MX357717B (es) 2018-07-20
FI3351936T3 (fi) 2025-03-17
ES2673697T5 (es) 2022-09-14
SI3351936T1 (sl) 2025-05-30
CY1120633T1 (el) 2019-12-11
LT2726883T (lt) 2018-06-11
AU2012276280A1 (en) 2014-01-09
AU2019222928A1 (en) 2019-09-19
TR201808740T4 (tr) 2018-07-23
LT3351936T (lt) 2025-02-25
RU2013154967A (ru) 2015-08-10
EP4556906A2 (en) 2025-05-21
DK2726883T4 (da) 2022-08-22
US9983207B2 (en) 2018-05-29
ES3009107T3 (en) 2025-03-26
DK3351936T3 (da) 2025-03-10
CA2840484A1 (en) 2013-01-03
US20190101536A1 (en) 2019-04-04
CN115144594B (zh) 2025-09-05
EP2726883B1 (en) 2018-03-28
MX2013015259A (es) 2014-04-16
BR112013033520A2 (pt) 2017-02-07
RU2018107763A3 (pl) 2021-06-01
BR112013033520B1 (pt) 2021-03-09
CN103703375B (zh) 2018-04-10
EP2726883A1 (en) 2014-05-07
DK2726883T3 (en) 2018-07-16
AU2025200713A1 (en) 2025-02-20

Similar Documents

Publication Publication Date Title
ZA201309155B (en) A cell mediated immune response assay with enhanced sensitivity
GB2488600B (en) A force sensor
GB2488841B (en) Sensor array
HUE038527T2 (hu) Sejtek által közvetített immunválasz
PL2729809T3 (pl) Test oznaczający
GB201106615D0 (en) Assay
GB201212550D0 (en) B cell assay
EP2757363A4 (en) PLASMON SURFACE RESONANCE SENSOR CELL (SPR) AND SPR SENSOR
EP2725343A4 (en) SPR SENSOR CELL AND SPR SENSOR
GB201102659D0 (en) Assay
GB201121265D0 (en) Assay
GB201113101D0 (en) Assay
PL2707497T3 (pl) Wykrywanie mutacji Brachyspina
LT3421997T (lt) Imuninio atsako, kuriam tarpininkauja ląstelės, tyrimas
IL227892A0 (en) Optical sensor with improved sensitivity
GB201416623D0 (en) Cell migration assay
GB201103968D0 (en) Detecting polypeptides
GB201115537D0 (en) Assay
GB201115091D0 (en) Assay
GB201121573D0 (en) Assay
GB201101664D0 (en) Assay
GB201114404D0 (en) Assay
GB201117309D0 (en) Assay
GB201111608D0 (en) Assay
GB201107431D0 (en) Assay